We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
(+3.3%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$12.1M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$11.5M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$7.47M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$65.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$17.5M |
| 3 |
Plains All American Pipeline
PAA
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$15.4M |
| 5 |
Targa Resources
TRGP
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Financials | 13.41% |
| 3 | Healthcare | 12.54% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Apyx Medical
APYX
$126M
| $144K | ﹤0.01% |
+14,882
| New | +$149K |
|
2202
Matrix Service
MTRX
$330M
| $143K | ﹤0.01% |
+10,886
| New | +$145K |
|
|
AMNB
2203
DELISTED
American National Bankshares Inc
AMNB
| $143K | ﹤0.01% |
4,311
| – | – |
|
2204
MasterCraft Boat Holdings
MCFT
$600M
| $142K | ﹤0.01% |
5,356
-4,300
| -45% | -$119K |
|
|
CBAY
2205
DELISTED
Cymabay Therapeutics
CBAY
| $142K | ﹤0.01% |
31,252
+15,959
| +104% | +$85.9K |
|
2206
Sterling Infrastructure
STRL
$16.8B
| $142K | ﹤0.01% |
6,107
-1,710
| -22% | -$37.3K |
|
2207
VirnetX Holding Corp
VHC
$65.8M
| $142K | ﹤0.01% |
1,271
+930
| +273% | +$117K |
|
2208
W&T Offshore
WTI
$555M
| $141K | ﹤0.01% |
+39,232
| New | +$122K |
|
|
CMO
2209
DELISTED
Capstead Mortgage Corp.
CMO
| $141K | ﹤0.01% |
22,553
-20,355
| -47% | -$120K |
|
2210
Transcat
TRNS
$915M
| $140K | ﹤0.01% |
+2,858
| New | +$123K |
|
|
PSTX
2211
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $140K | ﹤0.01% |
+14,683
| New | +$144K |
|
|
CTO
2212
CTO Realty Growth
CTO
$819M
| $140K | ﹤0.01% |
+8,088
| New | +$131K |
|
2213
Veru
VERU
$46.7M
| $139K | ﹤0.01% |
1,294
-1,035
| -44% | -$130K |
|
2214
Quantum Corp
QMCO
$864M
| $139K | ﹤0.01% |
+836
| New | +$133K |
|
2215
Seneca Foods Class A
SENEA
$1.28B
| $138K | ﹤0.01% |
+2,922
| New | +$140K |
|
2216
Ooma
OOMA
$553M
| $136K | ﹤0.01% |
8,609
-649
| -7% | -$10.1K |
|
2217
NWPX Infrastructure Inc
NWPX
$1.1B
| $135K | ﹤0.01% |
+4,049
| New | +$131K |
|
2218
Greif Class B
GEF.B
$4.24B
| $135K | ﹤0.01% |
2,362
+85
| +4% | +$4.46K |
|
2219
InfuSystem Holdings
INFU
$244M
| $135K | ﹤0.01% |
+6,622
| New | +$124K |
|
|
SYRS
2220
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $134K | ﹤0.01% |
1,785
+56
| +3% | +$5.82K |
|
2221
Artesian Resources
ARTNA
$362M
| $133K | ﹤0.01% |
3,384
-382
| -10% | -$14.9K |
|
2222
Citizens
CIA
$199M
| $133K | ﹤0.01% |
22,933
+761
| +3% | +$4.69K |
|
|
NEX
2223
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $132K | ﹤0.01% |
35,434
-38,085
| -52% | -$154K |
|
2224
Intrepid Potash
IPI
$490M
| $132K | ﹤0.01% |
+4,043
| New | +$119K |
|
2225
Noodles & Co
NDLS
$98M
| $131K | ﹤0.01% |
+1,581
| New | +$123K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.
- MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
- MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
- MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
- MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
- MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
- MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
- MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.
Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.